Jorge Huete‐Carrasco

Statistics

Publications

Citations

H-Index

Active since

2020

Affiliations

Jorge Huete‐Carrasco is an author at AstraZeneca (United Kingdom) specializing in cancer immunotherapy, programmed death-1 inhibition, and tumor-infiltrating lymphocytes.

ORCID

Publications per year

2020–2024

Publications

PD-1 suppresses the maintenance of cell couples between cytotoxic T cells and target tumor cells within the tumor

Rachel Ambler, Grace L. Edmunds, Sin Lih Tan et al. · Science Signaling · 2020 · 27 citations · Full text

Medicine, Cancer Biology, Immunology +16

Intratumoral delivery of the chitin-derived C100 adjuvant promotes robust STING, IFNAR, and CD8+ T cell-dependent anti-tumor immunity

Joanna L. Turley, Ross W. Ward, Jorge Huete‐Carrasco et al. · Cell Reports Medicine · 2024 · 16 citations · Full text

Medicine, Immunology, Oncology +17

1–2 of 2